
Colour schemes: Germany’s coming coalition
Economist Podcasts
00:00
Innovating HIV Vaccines with mRNA Technology
This chapter explores the challenges of developing an effective HIV vaccine due to the virus's mutation rate and introduces Moderna's mRNA approach to stimulate unique immune responses. It highlights the potential breakthroughs from this technology and the lessons learned from COVID-19 vaccine development that may influence future HIV vaccine efforts.
Play episode from 14:20
Transcript


